Phase 1 dose escalation trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population, is enrolling well and remains on track Preclinical ...

Adverse events reported in oncology clinical trials don’t always match what patients experience. What is behind this disconnect and is it possible to reconcile?

Antibody-drug conjugates are currently being investigated in more than 260 clinical trials.“It’s going to be the next novel ...

Immunotherapy is a revolutionary cancer treatment. It uses the body's immune system to fight cancer cells. This approach offers hope for patients who haven't responded to traditional treatments.

CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its ...

A two-drug combination for treating advanced kidney cancer had sustained and durable clinical benefit in more than five years of follow-up, according to a study published Aug. 1 in Nature Medicine.

The firm is leveraging its expertise in the immuno-oncology space to expedite development of newer agents like the bispecific ...

A new mum put her symptoms of fatigue and breathlessness down to pregnancy. But tests finally revealed the devastating ...

As Keytruda generic competition looms larger on the horizon, the company is hoping to reinvest the savings into pipeline ...